Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Swedish (OMX) Healthtech Industry Analysis

UpdatedJun 29, 2026
DataAggregated Company Financials
Companies9
  • 7D-0.9%
  • 3M20.0%
  • 1Y-25.0%
  • YTD9.8%

In the last week, Healthtech has been flat. Unfortunately though, the industry is down 25% over the past 12 months. Earnings are forecast to grow by 24% annually.

Industry Valuation and Performance

Has the Swedish Healthtech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 29 Jun 2026SEK 62.7bSEK 5.8bSEK 155.0m38.6x404.7x10.7x
Wed, 27 May 2026SEK 64.2bSEK 5.7bSEK 131.7m40.1x487.6x11.2x
Fri, 24 Apr 2026SEK 62.4bSEK 5.7bSEK 273.6m37.9x227.9x10.8x
Sun, 22 Mar 2026SEK 51.9bSEK 5.7bSEK 267.7m44.4x193.7x9x
Tue, 17 Feb 2026SEK 43.0bSEK 5.6bSEK 744.2m46.6x57.7x7.6x
Thu, 15 Jan 2026SEK 55.1bSEK 5.6bSEK 681.6m51.9x80.9x9.9x
Sat, 13 Dec 2025SEK 61.7bSEK 5.5bSEK 618.3m61.6x99.8x11.2x
Mon, 10 Nov 2025SEK 68.3bSEK 5.5bSEK 634.9m68.5x107.6x12.4x
Wed, 08 Oct 2025SEK 70.1bSEK 5.4bSEK 577.7m72.2x121.4x12.9x
Fri, 05 Sep 2025SEK 74.4bSEK 5.5bSEK 544.1m43x136.8x13.6x
Sun, 03 Aug 2025SEK 82.1bSEK 5.5bSEK 605.2m85.5x135.7x14.9x
Tue, 01 Jul 2025SEK 82.1bSEK 5.5bSEK 615.2m85.6x133.4x14.9x
Thu, 29 May 2025SEK 73.1bSEK 5.5bSEK 641.1m73.9x114x13.3x
Sat, 26 Apr 2025SEK 65.9bSEK 5.4bSEK 621.5m69.2x106x12.2x
Mon, 24 Mar 2025SEK 59.6bSEK 5.4bSEK 615.9m65.9x96.8x11x
Wed, 19 Feb 2025SEK 62.3bSEK 5.2bSEK 473.2m81.5x131.6x11.9x
Fri, 17 Jan 2025SEK 59.5bSEK 5.2bSEK 490.7m63.2x121.2x11.4x
Sun, 15 Dec 2024SEK 62.5bSEK 5.2bSEK 490.8m65.9x127.3x12x
Tue, 12 Nov 2024SEK 8.0bSEK 1.8bSEK 95.7m45.3x83.1x4.5x
Thu, 10 Oct 2024SEK 61.1bSEK 5.0bSEK 528.6m41.1x115.6x12.2x
Sat, 07 Sep 2024SEK 55.6bSEK 5.0bSEK 531.2m40.1x104.7x11.1x
Mon, 05 Aug 2024SEK 50.9bSEK 4.8bSEK 476.2m65.3x106.9x10.6x
Wed, 03 Jul 2024SEK 52.9bSEK 4.8bSEK 459.9m70.2x115x11.1x
Fri, 31 May 2024SEK 51.5bSEK 4.6bSEK 457.0m65.6x112.8x11.2x
Sun, 28 Apr 2024SEK 49.4bSEK 4.7bSEK 473.9m100.6x104.2x10.5x
Tue, 26 Mar 2024SEK 47.0bSEK 4.7bSEK 473.7m95.6x99.2x10x
Thu, 22 Feb 2024SEK 46.5bSEK 4.6bSEK 318.5m115.2x145.9x10.2x
Sat, 20 Jan 2024SEK 42.0bSEK 4.6bSEK 340.3m144x123.4x9.2x
Mon, 18 Dec 2023SEK 36.9bSEK 4.6bSEK 340.3m133x108.3x8.1x
Wed, 15 Nov 2023SEK 33.2bSEK 4.3bSEK 297.3m74.6x111.6x7.7x
Fri, 13 Oct 2023SEK 30.3bSEK 4.2bSEK 312.6m75.8x96.8x7.1x
Sun, 10 Sep 2023SEK 37.0bSEK 4.3bSEK 312.7m82.7x118.3x8.7x
Tue, 08 Aug 2023SEK 37.0bSEK 4.0bSEK 292.2m99.6x126.6x9.1x
Thu, 06 Jul 2023SEK 39.2bSEK 4.0bSEK 273.1m96.5x143.5x9.7x
Price to Earnings Ratio

143.5x


Total Market Cap: SEK 39.2bTotal Earnings: SEK 273.1mTotal Revenue: SEK 4.0bTotal Market Cap vs Earnings and Revenue0%0%0%
Swedish Healthtech Industry Price to Earnings3Y Average 130.9x202420252026
Current Industry PE
  • Investors are optimistic on the Swedish Healthcare Services industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 405x which is higher than its 3-year average PE of 131x.
  • The industry is trading close to its 3-year average PS ratio of 10.6x.
Past Earnings Growth
  • The earnings for companies in the Healthcare Services industry have declined 17% per year over the last three years.
  • Meanwhile revenues for these companies have grown 13% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the Swedish Healthcare industry?

SE Market-0.81%
Healthcare3.43%
Healthtech-0.93%
Healthtech-0.93%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
RAY B RaySearch LaboratoriesSEK 209.800.6%
+SEK 41.1m		-37.4%PE32.1x
MNTC MenticeSEK 13.002.4%
+SEK 8.4m		-14.5%PS1.3x
AINO Aino HealthSEK 0.134.9%
+SEK 1.2m		-32.6%PS1.1x

Latest News

MNTC
SEK 13.00
Mentice
7D
2.4%
1Y
-14.5%
Narrative Update • Jun 26

MNTC: New Imaging Partnership Will Drive Future Demand For Aneurysm Planning Tools

Analysts have adjusted their 12 month price target for Mentice to SEK28.50 from SEK20.50, citing updated assumptions around discount rates, long term revenue growth, profit margins, and future P/E multiples. What’s in the News for Mentice Mentice has entered into a co-marketing agreement with Siemens Healthineers to link its Ankyras clinical decision-support software with Siemens Healthineers ARTIS icono angiography systems.
CARA
SEK 22.90
Carasent
7D
-2.8%
1Y
-23.2%
Narrative Update • Jun 26

CARA: Higher Growth Outlook And Governance Changes Will Support Upside

Analysts have lifted their price target on Carasent to SEK34.00 from SEK25.27. This reflects updated assumptions that pair higher projected revenue growth with a lower profit margin and a much richer forward P/E multiple.
SECT B
SEK 273.80
Sectra
7D
-0.1%
1Y
-21.9%
Narrative Update • Jun 26

SECT B: Cloud Contracts And Margin Assumptions Will Likely Prove Overoptimistic

Analysts have raised their price target for Sectra from SEK115 to SEK220, citing updated assumptions for revenue growth, profit margins and future P/E levels as the main factors behind this revision. What’s in the News for Sectra MVZ MedDiagnost GmbH, part of the LifeLink Group, signed a 10 year agreement to roll out Sectra One across 10 practice locations in the Aachen region, consolidating three separate imaging systems into a single enterprise imaging platform.
QCORE
SEK 0.32
Qlucore
7D
-20.8%
1Y
-58.1%
RAY B
SEK 209.80
RaySearch Laboratories
7D
0.6%
1Y
-37.4%
Narrative Update • Jun 22

RAY B: Global Oncology Expansion Into New Markets Will Support Stronger Prospects

Analysts now keep their SEK 330.00 price target for RaySearch Laboratories broadly unchanged, indicating only minor adjustments in inputs such as the discount rate, long term revenue growth, profit margin and future P/E assumptions. What’s in the News for RaySearch Laboratories RaySearch Laboratories received an order from Tam Anh General Hospital in Vietnam for the RayStation treatment planning system, supporting advanced proton therapy with the MEVION Proton Therapy System and marking the company’s entry into the Vietnamese market.
H100
SEK 1.12
H100 Group
7D
-8.2%
1Y
-87.9%
IZAFE B
SEK 0.35
iZafe Group
7D
-12.8%
1Y
40.7%
AINO
SEK 0.13
Aino Health
7D
4.9%
1Y
-32.6%
PTRK
SEK 7.98
Physitrack
7D
-2.7%
1Y
-41.5%
ORTI B
SEK 1.78
Ortivus
7D
-3.0%
1Y
31.9%
KONT
SEK 2.09
Kontigo Care
7D
-9.1%
1Y
-18.4%